Pulmonary embolism treatment study
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at different ways to manage pulmonary embolism, a blood clot in the lungs. It aims to find the best treatment to help patients recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a pulmonary embolism (a blood clot in your lungs).
- Your doctor agrees that you can participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at when it's best to give treatment to restore blood flow in people with a serious type of pulmonary embolism. It aims to find the optimal time for this procedure to improve outcomes.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
This study looks at how well certain scores, blood tests, and CT scan findings predict the severity of a pulmonary embolism (blood clot in the lungs). By joining, you may help doctors better understand and treat this condition.
Hear when a new Pulmonary Embolism (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.